1,264
Participants
Start Date
September 1, 2017
Primary Completion Date
December 31, 2017
Study Completion Date
December 31, 2017
Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council, Palermo
Istituto per la Ricerca e l'Innovazione Biomedica
OTHER